Leukemia Chemotherapy
CSEF · 2009 Pharmacology (Senior Division Only)
Overview
Objectives/Goals My objective was to determine which drug combination [Clofarabine and Busulfan vs. Clofarabine and Melphalan] is more synergistic in DNA damage on Acute Lymphoblastic Leukemia [ALL] cells. I hypothesize that Clofarabine in combinations with Busulfan will have better synergistic results. Methods/Materials Methods: Western Blotting, MTS assay, Calcusyn program and cell culturing. Materials: Reh [human leukemia cell line], general pre-clinical laboratory equipment. Results The Calcusyn program showed Clofarabine in combination with Busulfan to have better synergistic results. The Western Blotting tracing the yH2AX protein expression also showed Clofarabine in combination with Busulfan to have better synergistic results. Conclusions/Discussion The hypothesis was correct, Clofarabine in combination with Busulfan does have better synergistic effect than Clofarabine in combination with Melphalan.
Summary statement
Pre-Clinical study comparing Clofarabine in combination with Busulfan versus Melphalan on Reh.
Help received
City of Hope Eugene and Ruth Roberts Summer Academy Program. Mentors: Dr. Shika and Dr. Gaur.
Competition history
- CSEF 2009
Resources
Related projects
CSEF · 2009
Rescuing a Failed Acute Myeloid Leukemia Drug (Troxatyl) using Biomarkers
CSEF · 2015
DNA Damage Induced by a Novel Drug Cocktail Regulates Chemokine Production in Leukemia through Cytosolic DNA Sensing
CSEF · 2018
A Precision Medicine Approach: Epigenetic Inhibitors Induce Highly-Specific Apoptosis in High Risk Acute Leukemia
CSEF · 2014
Development of a Novel Computer-Aided Framework for the Discovery of Synergistic Chemotherapy Combinations
ISEF · 2019
Precision Care for Leukemia: Discovery of Novel Therapeutics for High-Risk ALL via Epigenetic and Computational Transcriptome Profiling
ISEF · 2014
Fighting for the Orange Ribbon: Acute Myeloid Leukemia Type-3 Differentiation Triggered by Cisplatin
ISEF · 2017
The Synergistic Effect of Imatinib and Allicin: A Potential Therapeutic for BCR-ABL1-positive Leukemia
CSEF · 2010
Sensitization of CD44+ Cancer Stem Cell Apoptosis by Sequential Inhibition of the S-Phase
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: California Science & Engineering Fair public projects